Cash flow RadNet, Inc.

Stocks

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 00:00:00 27/06/2026 +04			5-day change	1st Jan Change
60.74 ^USD	+1.22%		+13.03%	-14.87%

06-25	RadNet Unit DeepHealth Wins FDA Clearance for Two Breast Imaging AI Tools	MT
06-11	Radnet, Inc. Enters into Incremental Amendment No. 3 to Credit and Guaranty Agreement, Secures $250 Million Incremental Term Loan and Reduces Interest Rates on Credit Facility	CI

3cd268b300235a1ea2f161b47c8.mtOG_aCSGj5VrTKTixPzLoglQve4GkFFZixBx-9kCQM.9r-ylerHbQ8i9FD6vXW6Srp1JZHQbwYNLlYmro0gTHDWt-7O5d9bcTPIaw

Published financial data: RADNET, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.18B	1.28B	1.46B	1.69B	1.91B
Other Revenues, Total	148M	152M	153M	137M	126M
Total Revenues	1.32B	1.43B	1.62B	1.83B	2.04B
Cost of Goods Sold, Total	1B	1.14B	1.25B	1.47B	1.68B
Gross Profit	323M	289M	368M	361M	359M
Selling General & Admin Expenses, Total	122M	123M	118M	110M	116M
Stock-Based Compensation (IS)	-	-	24.58M	-	-
Depreciation & Amortization - (IS)	96.69M	116M	128M	138M	152M
Other Operating Expenses, Total	219M	239M	271M	248M	268M
Operating Income	104M	49.84M	96.95M	113M	90.8M
Interest Expense, Total	-27.16M	-11.22M	-72.67M	-87.86M	-77.02M
Net Interest Expenses	-27.16M	-11.22M	-72.67M	-87.86M	-77.02M
Income (Loss) On Equity Invest.	10.97M	10.39M	6.43M	14.47M	14.88M
Other Non Operating Income (Expenses)	-1.44M	-1.83M	6.35M	24.92M	32.07M
EBT, Excl. Unusual Items	86.59M	47.18M	37.06M	64.08M	60.72M
Restructuring Charges	-744K	-946K	-3.78M	-1.9M	-3.14M
Merger & Related Restructuring Charges	-	-	-	-	-7.45M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	16.81M	-	-
Gain (Loss) On Sale Of Assets	-1.25M	-2.53M	-2.19M	-2.28M	-9.66M
Asset Writedown	-	-	-9.1M	-3.75M	-8.56M
Other Unusual Items	-25.72M	-731K	-	-11.29M	-
EBT, Incl. Unusual Items	58.88M	42.97M	38.81M	44.86M	31.91M
Income Tax Expense	14.56M	9.36M	8.47M	6.03M	14.86M
Earnings From Continuing Operations	44.32M	33.61M	30.34M	38.84M	17.05M
Net Income to Company	44.32M	33.61M	30.34M	38.84M	17.05M
Minority Interest	-19.59M	-22.96M	-27.29M	-36.04M	-35.7M
Net Income - (IS)	24.73M	10.65M	3.04M	2.79M	-18.65M
Net Income to Common Incl Extra Items	24.73M	10.65M	3.04M	2.79M	-18.65M
Net Income to Common Excl. Extra Items	24.73M	10.65M	3.04M	2.79M	-18.65M
Per Share Items
Net EPS - Basic	0.47	0.19	0.05	0.04	-0.25
Basic EPS - Continuing Operations	0.47	0.19	0.05	0.04	-0.25
Basic Weighted Average Shares Outstanding	52.5M	56.29M	63.58M	73.04M	75.19M
Net EPS - Diluted	0.46	0.17	0.05	0.04	-0.25
Diluted EPS - Continuing Operations	0.46	0.17	0.05	0.04	-0.25
Diluted Weighted Average Shares Outstanding	53.42M	57.32M	64.66M	74.76M	75.19M
Normalized Basic EPS	0.66	0.12	-0.06	0.05	0.03
Normalized Diluted EPS	0.65	0.11	-0.06	0.05	0.03
Supplemental Items
EBITDA	201M	166M	225M	250M	243M
EBITA	109M	59.94M	109M	125M	107M
EBIT	104M	49.84M	96.95M	113M	90.8M
EBITDAR	323M	289M	343M	361M	359M
Total Revenues (As Reported)	-	-	-	1.83B	2.04B
Effective Tax Rate - (Ratio)	24.73	21.79	21.83	13.43	46.58
Current Domestic Taxes	-2.19M	371K	3.44M	2.38M	4.04M
Current Foreign Taxes	18K	87K	638K	1.3M	1.02M
Total Current Taxes	-2.17M	458K	4.08M	3.68M	5.06M
Deferred Domestic Taxes	16.73M	12.33M	6.24M	3.02M	11.52M
Deferred Foreign Taxes	-	-3.43M	-1.84M	-674K	-1.72M
Total Deferred Taxes	16.73M	8.9M	4.39M	2.35M	9.8M
Normalized Net Income	34.53M	6.53M	-4.13M	4.01M	2.25M
Interest on Long-Term Debt	4.65M	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	-	1.31M	15M	20.16M
Net Rental Expense, Total	122M	123M	118M	110M	116M
Imputed Operating Lease Interest Expense	20.52M	7.59M	45.53M	48.09M	39.85M
Imputed Operating Lease Depreciation	101M	115M	72.13M	62.07M	76.17M
Stock-Based Comp., COGS (Total)	25.2M	23.77M	-	26.86M	44.67M
Stock-Based Comp., Other (Total)	-	-	26.78M	2.97M	9.93M
Total Stock-Based Compensation	25.2M	23.77M	26.78M	29.83M	54.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	135M	128M	343M	740M	767M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	135M	128M	343M	740M	767M
Accounts Receivable, Total	135M	166M	164M	186M	200M
Other Receivables	5.38M	18.97M	25.34M	41.87M	12.59M
Total Receivables	140M	185M	189M	228M	213M
Prepaid Expenses	49.21M	54.02M	47.66M	51.54M	52M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	324M	367M	579M	1.02B	1.03B
Gross Property Plant And Equipment	1.75B	1.92B	2.04B	2.27B	2.45B
Accumulated Depreciation	-677M	-755M	-837M	-936M	-952M
Net Property Plant And Equipment	1.07B	1.17B	1.2B	1.33B	1.5B
Long-term Investments	42.23M	57.89M	92.71M	104M	130M
Goodwill	514M	678M	679M	711M	908M
Other Intangibles, Total	56.6M	106M	90.62M	81.35M	149M
Deferred Tax Assets Long-Term	14.85M	-	-	-	-
Deferred Charges Long-Term	2.14M	2.28M	1.64M	2.26M	1.68M
Other Long-Term Assets, Total	36.03M	53.17M	46.33M	34.57M	40.29M
Total Assets	2.06B	2.43B	2.69B	3.29B	3.76B
Liabilities
Accounts Payable, Total	86.46M	103M	123M	96.45M	153M
Accrued Expenses, Total	177M	267M	220M	255M	269M
Current Portion of Long-Term Debt	11.16M	12.4M	17.97M	24.69M	25.42M
Current Portion of Leases	65.45M	57.61M	55.98M	56.62M	61.93M
Unearned Revenue Current, Total	10.7M	4.02M	4.65M	3.29M	7.27M
Other Current Liabilities	23.53M	23.1M	15.91M	43.65M	70.1M
Total Current Liabilities	375M	467M	437M	480M	587M
Long-Term Debt	743M	839M	812M	992M	1.06B
Long-Term Leases	578M	604M	605M	656M	707M
Deferred Tax Liability Non Current	-	9.26M	15.78M	22.23M	21.9M
Other Non Current Liabilities	16.36M	23.02M	6.72M	3.78M	22.52M
Total Liabilities	1.71B	1.94B	1.88B	2.15B	2.4B
Common Stock, Total	5K	6K	7K	7K	8K
Additional Paid In Capital	343M	436M	723M	988M	1.18B
Retained Earnings	-93.27M	-82.62M	-79.58M	-76.78M	-95.44M
Comprehensive Income and Other	-20.42M	-20.68M	-12.48M	-9.06M	4.88M
Total Common Equity	229M	333M	631M	902M	1.09B
Minority Interest	117M	158M	183M	231M	266M
Total Equity	346M	491M	813M	1.13B	1.36B
Total Liabilities And Equity	2.06B	2.43B	2.69B	3.29B	3.76B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	56.18M	57.84M	68.48M	74.04M	77.61M
ECS Total Common Shares Outstanding	53.55M	57.72M	67.96M	74.04M	77.4M
Book Value / Share	4.27	5.77	9.28	12.19	14.08
Tangible Book Value	-342M	-451M	-139M	110M	33.72M
Tangible Book Value Per Share	-6.38	-7.81	-2.05	1.49	0.44
Total Debt	1.4B	1.51B	1.49B	1.73B	1.86B
Net Debt	1.26B	1.39B	1.15B	989M	1.09B
Debt Equivalent Oper. Leases	976M	984M	941M	881M	928M
Minority Interest, Total (Incl. Fin. Div)	117M	158M	183M	231M	266M
Equity Method Investments, Total	42.23M	57.89M	92.71M	104M	130M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	250K	250K	250K	250K	250K
Machinery, Total	696M	737M	828M	910M	925M
Full Time Employees	6.76K	6.95K	7.87K	8.55K	8.84K
Part Time Employees	527	509	569	454	432
Assets under Capital Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	24.73M	10.65M	3.04M	2.79M	-18.65M
Depreciation & Amortization - CF	166M	175M	177M	125M	196M
Amortization of Goodwill and Intangible Assets - (CF)	4.4M	10.1M	12.2M	12.5M	16.1M
Depreciation & Amortization, Total	171M	185M	189M	138M	212M
Amortization of Deferred Charges, Total - (CF)	3.25M	2.69M	2.99M	3.09M	3.01M
(Gain) Loss From Sale Of Asset	1.25M	2.53M	2.19M	2.28M	9.66M
(Gain) Loss on Sale of Investments - (CF)	-21.67M	-39.62M	-8.62M	8.01M	7.11M
Asset Writedown & Restructuring Costs	19.68M	-	9.1M	3.75M	8.56M
(Income) Loss On Equity Investments - (CF)	-6.26M	-5.95M	9.18M	-9.93M	-5.8M
Stock-Based Compensation (CF)	25.2M	23.77M	26.78M	29.83M	54.6M
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	24.78M	26.32M	26.99M	112M	38.08M
Change In Accounts Receivable	-5.89M	-30.08M	2.65M	-21.77M	-9.56M
Change In Accounts Payable	9.92M	49.78M	15.09M	37.12M	52.42M
Change in Unearned Revenues	-28.32M	-7.32M	626K	-1.36M	2.81M
Change In Deferred Taxes	19.83M	13.36M	6.06M	6.45M	10.83M
Change in Other Net Operating Assets	-87.67M	-84.44M	-64.69M	-76.93M	-66.25M
Cash from Operations	149M	146M	221M	233M	299M
Capital Expenditure	-138M	-119M	-177M	-188M	-213M
Sale of Property, Plant, and Equipment	625K	3.9M	83K	157K	1.29M
Cash Acquisitions	-77.69M	-130M	-10.92M	-43.66M	-133M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-5.13M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-1.44M	-1.44M	-14.04M	-1.5M	-4.15M
Other Investing Activities, Total	-	-	-	-	5.67M
Cash from Investing	-222M	-247M	-201M	-233M	-344M
Long-Term Debt Issued, Total	846M	148M	-	864M	99M
Total Debt Issued	846M	148M	-	864M	99M
Long-Term Debt Repaid, Total	-751M	-53.75M	-43.99M	-698M	-27.78M
Total Debt Repaid	-751M	-53.75M	-43.99M	-698M	-27.78M
Issuance of Common Stock	488K	294K	246M	219M	5.45M
Other Financing Activities, Total	9.71M	-893K	-6.35M	13.57M	-4.46M
Cash from Financing	105M	93.65M	196M	398M	72.21M
Foreign Exchange Rate Adjustments	-65K	113K	-292K	-453K	33K
Net Change in Cash	32.59M	-6.77M	215M	397M	27.2M
Supplemental Items
Cash Interest Paid	29.04M	39.15M	64.7M	84.6M	72.27M
Cash Income Tax Paid (Refund)	1.95M	587K	1.59M	4.17M	4.56M
Levered Free Cash Flow	91.24M	165M	27.27M	-9.49M	180M
Unlevered Free Cash Flow	105M	169M	69.7M	42.32M	225M
Change In Net Working Capital	13.04M	-48.86M	30.58M	7.62M	-115M
Net Debt Issued / Repaid	94.48M	94.25M	-43.99M	165M	71.22M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.39	1.39	2.36	2.35	1.61
Return on Total Capital	4.09	1.66	2.81	2.72	1.87
Return On Equity %	14.66	8.02	4.65	3.99	1.37
Return on Common Equity	12.53	3.79	0.63	0.36	-1.87
Margin Analysis
Gross Profit Margin %	24.38	20.19	22.74	19.71	17.59
SG&A Margin	9.21	8.6	7.28	6.02	5.69
EBITDA Margin %	15.17	11.59	13.94	13.68	11.91
EBITA Margin %	8.2	4.19	6.75	6.83	5.24
EBIT Margin %	7.87	3.48	6	6.15	4.45
Income From Continuing Operations Margin %	3.35	2.35	1.88	2.12	0.84
Net Income Margin %	1.87	0.74	0.19	0.15	-0.91
Net Avail. For Common Margin %	1.87	0.74	0.19	0.15	-0.91
Normalized Net Income Margin	2.61	0.46	-0.26	0.22	0.11
Levered Free Cash Flow Margin	6.89	11.52	1.69	-0.52	8.84
Unlevered Free Cash Flow Margin	7.93	11.82	4.31	2.31	11.05
Asset Turnover
Asset Turnover	0.69	0.64	0.63	0.61	0.58
Fixed Assets Turnover	1.36	1.28	1.36	1.44	1.44
Receivables Turnover (Average Receivables)	8.89	8.48	8.87	9.69	9.92
Short Term Liquidity
Current Ratio	0.87	0.79	1.32	2.12	1.76
Quick Ratio	0.73	0.67	1.22	2.02	1.67
Operating Cash Flow to Current Liabilities	0.4	0.31	0.5	0.49	0.51
Days Sales Outstanding (Average Receivables)	41.07	43.04	41.17	37.78	36.81
Average Days Payable Outstanding	28.53	30.24	32.96	27.32	27.1
Long Term Solvency
Total Debt/Equity	403.8	307.96	183.33	152.54	137.1
Total Debt / Total Capital	80.15	75.49	64.71	60.4	57.82
LT Debt/Equity	381.67	293.71	174.24	145.36	130.65
Long-Term Debt / Total Capital	75.76	72	61.5	57.56	55.11
Total Liabilities / Total Assets	83.18	79.81	69.77	65.52	63.93
EBIT / Interest Expense	3.84	4.44	1.33	1.28	1.18
EBITDA / Interest Expense	11.89	25.74	4.72	4.1	4.66
(EBITDA - Capex) / Interest Expense	6.81	15.09	2.29	1.96	1.89
Total Debt / EBITDA	4.33	5.24	4.35	4.79	5.18
Net Debt / EBITDA	3.91	4.8	3.35	2.74	3.04
Total Debt / (EBITDA - Capex)	7.56	8.94	8.96	10.02	12.76
Net Debt / (EBITDA - Capex)	6.83	8.18	6.9	5.73	7.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.59	8	13.05	13.18	11.51
Gross Profit, 1 Yr. Growth %	34.3	43.73	18.63	9.39	-0.34
EBITDA, 1 Yr. Growth %	51.97	-17.52	35.98	11.12	-2.83
EBITA, 1 Yr. Growth %	121.19	-44.82	82.1	14.57	-14.24
EBIT, 1 Yr. Growth %	129.52	-52.18	94.53	16.09	-19.04
Earnings From Cont. Operations, 1 Yr. Growth %	-2.63K	-24.17	-9.73	28.02	-56.11
Net Income, 1 Yr. Growth %	-266.62	-56.93	-71.42	-8.25	-767.81
Normalized Net Income, 1 Yr. Growth %	-442.61	-81.1	-163.26	-197.12	-40.17
Diluted EPS Before Extra, 1 Yr. Growth %	-257.75	-62.36	-72.35	-20.13	-753.77
Accounts Receivable, 1 Yr. Growth %	4.23	23.17	-1.59	13.51	7.8
Net Property, Plant and Equip., 1 Yr. Growth %	21.01	9.45	2.65	11.17	12.25
Total Assets, 1 Yr. Growth %	15.21	18.24	10.54	22.16	14.36
Tangible Book Value, 1 Yr. Growth %	-5.01	32.03	-69.09	-179.13	-69.43
Common Equity, 1 Yr. Growth %	38.11	45.47	89.4	43.07	20.79
Cash From Operations, 1 Yr. Growth %	-36.05	-2.06	50.85	5.51	28.24
Capital Expenditures, 1 Yr. Growth %	46.41	-13.36	47.84	6.49	13.39
Levered Free Cash Flow, 1 Yr. Growth %	-47.8	80.54	-83.45	-71.95	254.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-47.68	61.06	-58.77	392.49	119.64
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.11	14.12	10.49	13.11	12.34
Gross Profit, 2 Yr. CAGR %	44.57	47.79	35.26	14.88	6.33
EBITDA, 2 Yr. CAGR %	14.04	11.96	5.9	22.92	6.74
EBITA, 2 Yr. CAGR %	18.79	10.48	0.24	44.44	4.97
EBIT, 2 Yr. CAGR %	18.77	4.77	-3.55	50.28	3.47
Earnings From Cont. Operations, 2 Yr. CAGR %	37.5	338.36	-17.26	7.5	-25.04
Net Income, 2 Yr. CAGR %	29.45	-15.29	-64.91	-48.79	147.54
Normalized Net Income, 2 Yr. CAGR %	70.47	-19.52	-65.42	-21.61	-56.15
Diluted EPS Before Extra, 2 Yr. CAGR %	25.94	-22.94	-67.74	-53.01	128.51
Accounts Receivable, 2 Yr. CAGR %	-6.58	13.3	10.09	5.69	10.62
Net Property, Plant and Equip., 2 Yr. CAGR %	14.62	15.08	5.99	6.82	11.71
Total Assets, 2 Yr. CAGR %	11.8	16.72	14.33	16.21	18.19
Tangible Book Value, 2 Yr. CAGR %	1.23	11.99	-36.12	-50.54	-50.82
Common Equity, 2 Yr. CAGR %	22.84	41.74	65.99	64.61	31.46
Cash From Operations, 2 Yr. CAGR %	19.71	-20.86	21.55	26.15	16.32
Capital Expenditures, 2 Yr. CAGR %	36.36	12.62	13.18	25.48	9.89
Levered Free Cash Flow, 2 Yr. CAGR %	-12.56	-2.92	-45.33	-68.54	507.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-14.97	-8.21	-18.51	-35.01	145.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.74	7.41	13.76	11.38	12.57
Gross Profit, 3 Yr. CAGR %	44.24	23.18	40.62	21.52	9.53
EBITDA, 3 Yr. CAGR %	23.14	2.37	19.45	7.61	13.6
EBITA, 3 Yr. CAGR %	42.67	-8	30.5	4.81	21.27
EBIT, 3 Yr. CAGR %	44.28	-12.3	28.77	2.6	22.14
Earnings From Cont. Operations, 3 Yr. CAGR %	5.14	12.76	158.86	-4.31	-20.25
Net Income, 3 Yr. CAGR %	-8.47	-10.3	-41.02	-51.66	20.54
Normalized Net Income, 3 Yr. CAGR %	102.81	-18.1	-25.73	-51.21	-29.86
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.34	-15.79	-45.24	-56.36	13.02
Accounts Receivable, 3 Yr. CAGR %	-3.2	2.44	8.1	11.22	6.39
Net Property, Plant and Equip., 3 Yr. CAGR %	45.66	12.87	10.78	7.69	8.6
Total Assets, 3 Yr. CAGR %	22.88	13.9	14.62	16.88	15.59
Tangible Book Value, 3 Yr. CAGR %	1	10.6	-27.08	-31.39	-57.87
Common Equity, 3 Yr. CAGR %	21.64	29.97	56.12	57.97	48.47
Cash From Operations, 3 Yr. CAGR %	8.59	11.96	-1.87	15.95	26.84
Capital Expenditures, 3 Yr. CAGR %	24.08	17.22	23.32	10.9	21.31
Levered Free Cash Flow, 3 Yr. CAGR %	32.94	11.35	-46.17	-52.97	23.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.12	5.21	-29.7	-26.12	31.03
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.4	9.17	10.64	9.65	13.19
Gross Profit, 5 Yr. CAGR %	12.03	19.24	27.85	18.47	22.11
EBITDA, 5 Yr. CAGR %	13.07	6.7	15.93	10.14	12.94
EBITA, 5 Yr. CAGR %	19.42	1.51	23.89	10.19	16.83
EBIT, 5 Yr. CAGR %	19.86	-1.23	22.81	8.78	14.87
Earnings From Cont. Operations, 5 Yr. CAGR %	40.82	74.54	-4.47	10.63	57.68
Net Income, 5 Yr. CAGR %	27.88	188.81	-37.63	-28.32	4.68
Normalized Net Income, 5 Yr. CAGR %	41.29	-14.58	-0.05	-19.52	-25.9
Diluted EPS Before Extra, 5 Yr. CAGR %	25.12	174.16	-40.83	-33.32	-3.03
Accounts Receivable, 5 Yr. CAGR %	-3.83	1.36	1.91	3.73	9.1
Net Property, Plant and Equip., 5 Yr. CAGR %	33.96	36.78	28.27	10.41	11.15
Total Assets, 5 Yr. CAGR %	19.37	22.87	19.39	14.82	16.04
Tangible Book Value, 5 Yr. CAGR %	7.88	13.86	-15.91	-19.84	-37.71
Common Equity, 5 Yr. CAGR %	36.4	40.16	37.75	42.85	45.74
Cash From Operations, 5 Yr. CAGR %	10.28	0.58	13.6	17.44	5.03
Capital Expenditures, 5 Yr. CAGR %	18.4	14.26	19.6	20.46	17.76
Levered Free Cash Flow, 5 Yr. CAGR %	10.89	20.39	-6.83	-39.73	0.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.52	14.2	2.34	-21.85	2.36